China Shineway Pharmaceutical Group Limited (FRA:C1S)

Market Cap	655.26M -6.1%
Revenue (ttm)	381.80M -17.0%
Net Income	115.67M +13.1%
EPS	0.15 +13.3%
Shares Out	n/a
PE Ratio	5.66
Forward PE	5.38
Dividend	0.07 (7.76%)
Ex-Dividend Date	May 4, 2026

Volume	n/a
Open	0.8400
Previous Close	0.8450
Day's Range	0.8400 - 0.8450
52-Week Range	0.7950 - 1.1000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovas...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 2,822
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: C1S

Financial Performance

In 2025, FRA:C1S's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error